Metformina Alter

Metformin, the active ingredient in Metformina Alter, is a biguanide presented as an oral tablet for oral use. It is used to improve blood glucose control in adults with type 2 diabetes mellitus and related insulin‑resistant conditions. GNH USA supplies Metformina Alter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformina Alter is a biguanide indicated for disorders of glucose metabolism. - Type 2 diabetes mellitus: lowers fasting and post‑prandial blood glucose levels to achieve glycaemic targets. - Prediabetes (impaired fasting glucose or impaired glucose tolerance): helps delay progression to overt diabetes by improving insulin sensitivity. - Polycystic ovary syndrome: reduces insulin resistance and may improve menstrual regularity and ovulation in women with PCOS.

Metformina Alter may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset, often transient. - Diarrhea: loose stools, usually early in therapy. - Abdominal discomfort: cramping or bloating. - Metallic taste: transient alteration of taste perception. - Weight loss: modest reduction in body weight. - Vitamin B12 deficiency: decreased absorption over long‑term use.

Serious or Rare Side Effects: - Lactic acidosis: a rare but life‑threatening metabolic disturbance. - Severe skin reactions: such as Stevens‑Johnson syndrome. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Hypoglycaemia: uncommon unless combined with other glucose‑lowering agents. - Persistent gastrointestinal bleeding: very rare. - Allergic reactions: rash, pruritus, or anaphylaxis.

Metformina Alter requires careful clinical monitoring to minimise risks. - Renal function: assess creatinine clearance before initiation and periodically thereafter. - Hepatic impairment: use with caution; monitor liver enzymes. - Lactic acidosis risk: avoid in patients with conditions predisposing to hypoxia or severe infection. - Vitamin B12 monitoring: consider periodic testing during long‑term therapy. - Alcohol consumption: limit intake to reduce lactic acidosis risk. - Contraindicated in severe renal failure: do not use when eGFR is below the recommended threshold. - Store at ambient temperature: keep in the original pack, protect from moisture and heat.

Metformina Alter can interact with several medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate acute renal failure and increase lactic acidosis risk. - Cimetidine: can raise metformin plasma concentrations, increasing toxicity. - Alcohol: potentiates risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycaemia symptoms. - Diuretics (especially thiazides): can affect renal clearance of metformin. - Corticosteroids: may raise blood glucose, requiring dose adjustments.